Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain : a descriptive analysis
Quintero, Javier (Universidad Complutense de Madrid)
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron)
Sebastián, Javier San (Hospital Universitario Ramón y Cajal (Madrid))
Montañés, Francisco (Hospital Universitario Fundación Alcorcón)
Fernández-Jaén, Alberto (Hospital Universitario Quirón. Madrid)
Martínez-Raga, José (Universitat de València)
García Giral, Marta (Hospital Clínic i Provincial de Barcelona)
Graell, Montserrat (Hospital Infantil Universitario Niño Jesús (Madrid))
Mardomingo, María J. (Hospital General Universitario Gregorio Marañón)
Soutullo, César (Clínica Universidad de Navarra)
Eiris, Jesús (Complejo Hospitalario Universitario de Santiago de Compostela)
Téllez, Montserrat (Hospital Universitari i Politècnic La Fe (València))
Pamias, Montserrat (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
Correas, Javier (Hospital Universitario del Henares ( Madrid))
Sabaté, Juncal (Shire. Madrid)
García-Orti, Laura (Shire. Madrid)
Alda, José A. (Hospital Sant Joan de Déu (Barcelona, Catalunya))
Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal

Fecha:	2018
Resumen:	Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition in childhood (5. 3% to 7. 1% worldwide prevalence), with substantial overall financial burden to children/adolescents, their families, and society. The aims of this study were to describe the clinical characteristics of children and adolescents with ADHD in Spain, estimate the associated direct/indirect costs of the disorder, and assess whether the characteristics and financial costs differed between children/adolescents adequately responding to currently available pharmacotherapies compared with children/adolescents for whom pharmacotherapies failed. This was a multicenter, cross-sectional, descriptive analysis conducted in 15 health units representative of the overall Spanish population. Data on demographic characteristics, socio-occupational status, social relationships, clinical variables of the disease, and pharmacological and non-pharmacological treatments received were collected in 321 children and adolescents with ADHD. Direct and indirect costs were estimated over one year from both a health care system and a societal perspective. The estimated average cost of ADHD per year per child/adolescent was €5733 in 2012 prices; direct costs accounted for 60. 2% of the total costs (€3450). Support from a psychologist/educational psychologist represented 45. 2% of direct costs and 27. 2% of total costs. Pharmacotherapy accounted for 25. 8% of direct costs and 15. 5% of total costs. Among indirect costs (€2283), 65. 2% was due to caregiver expenses. The total annual costs were significantly higher for children/adolescents who responded poorly to pharmacological treatment (€7654 versus €5517; P = 0. 024), the difference being mainly due to significantly higher direct costs, particularly with larger expenses for non-pharmacological treatment (P = 0. 012). ADHD has a significant personal, familial, and financial impact on the Spanish health system and society. Successful pharmacological intervention was associated with lower overall expenses in the management of the disorder. The online version of this article (10. 1186/s12888-017-1581-y) contains supplementary material, which is available to authorized users.
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	ADHD ; Adolescence ; School children ; Economic evaluation
Publicado en:	BMC Psychiatry, Vol. 18 (February 2018) , Núm. 40, ISSN 1471-244X

DOI: 10.1186/s12888-017-1581-y
PMID: 29422022

Published version 10 p, 533.9 KB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Instituto de Investigación e Innovación Parc Taulí (I3PT)
Artículos > Artículos de investigación
Artículos > Artículos publicados